Učitavanje...
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Tumour necrosis factor (TNF)-α is a key mediator of inflammation in rheumatoid arthritis, and its discovery led to the development of highly successful anti-TNF therapy. Subsequently, other biologic drugs targeting immune pathways, namely interleukin-6 blockade, B cell depletion, and T cell co-stimu...
Spremljeno u:
| Izdano u: | J Pers Med |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963853/ https://ncbi.nlm.nih.gov/pubmed/31581724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9040046 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|